par Michoux, Nicolas;Ceranka, Jakub;Vandemeulebroucke, Jef;Peeters, Frank;Lu, Pierre;Absil, Julie 
;Triqueneaux, Perrine;Liu, Yan;Collette, Laurence;Willekens, Inneke;Brussaard, C.;Debeir, Olivier ;Hahn, Stéphan ;Raeymaekers, Hubert;de Mey, Johan;Metens, Thierry ;Lecouvet, Frédéric
Référence European radiology
Publication Publié, 2021-01
;Triqueneaux, Perrine;Liu, Yan;Collette, Laurence;Willekens, Inneke;Brussaard, C.;Debeir, Olivier ;Hahn, Stéphan ;Raeymaekers, Hubert;de Mey, Johan;Metens, Thierry ;Lecouvet, FrédéricRéférence European radiology
Publication Publié, 2021-01
Article révisé par les pairs
| Résumé : | Multicenter oncology trials increasingly include MRI examinations with apparent diffusion coefficient (ADC) quantification for lesion characterization and follow-up. However, the repeatability and reproducibility (R&R) limits above which a true change in ADC can be considered relevant are poorly defined. This study assessed these limits in a standardized whole-body (WB)-MRI protocol. |
